DK447387A - Hexahydroarylquinolizinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse - Google Patents
Hexahydroarylquinolizinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelseInfo
- Publication number
- DK447387A DK447387A DK447387A DK447387A DK447387A DK 447387 A DK447387 A DK 447387A DK 447387 A DK447387 A DK 447387A DK 447387 A DK447387 A DK 447387A DK 447387 A DK447387 A DK 447387A
- Authority
- DK
- Denmark
- Prior art keywords
- hexahydroarylquinolizin
- compound
- connection
- pharmaceutical preparation
- preparation containing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 108020004101 alpha-2 Adrenergic Receptor Proteins 0.000 abstract 1
- 102000015006 alpha2-adrenergic receptor activity proteins Human genes 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90148586A | 1986-08-28 | 1986-08-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK447387D0 DK447387D0 (da) | 1987-08-27 |
| DK447387A true DK447387A (da) | 1988-02-29 |
Family
ID=25414273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK447387A DK447387A (da) | 1986-08-28 | 1987-08-27 | Hexahydroarylquinolizinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0259092B1 (da) |
| JP (1) | JP2582799B2 (da) |
| KR (1) | KR880002869A (da) |
| AT (1) | ATE78482T1 (da) |
| AU (1) | AU597412B2 (da) |
| CA (1) | CA1288435C (da) |
| DE (1) | DE3780542T2 (da) |
| DK (1) | DK447387A (da) |
| ES (1) | ES2044944T3 (da) |
| GR (1) | GR3005537T3 (da) |
| IL (1) | IL83586A (da) |
| NZ (1) | NZ221485A (da) |
| PT (1) | PT85593B (da) |
| ZA (1) | ZA876400B (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4942235A (en) * | 1989-03-16 | 1990-07-17 | Merck & Co., Inc. | Process for certain (2R-trans)hexahydroaroquinolizines |
| US5229387A (en) * | 1991-09-20 | 1993-07-20 | Syntex (U.S.A.) Inc. | Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo [2,3-e]quinolizine derivatives |
| FR2744451B1 (fr) * | 1996-02-01 | 1998-04-24 | Pf Medicament | Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique |
| US6141745A (en) * | 1998-04-30 | 2000-10-31 | Advanced Micro Devices, Inc. | Functional bit identifying a prefix byte via a particular state regardless of type of instruction |
| FI126838B (en) | 2014-12-16 | 2017-06-15 | Vetcare Oy | Process for the preparation of spirocyclic substituted benzofuroquinolizines |
| FI131529B1 (en) | 2024-01-16 | 2025-06-11 | Vetcare Oy | Process for the racemization of benzofuroquinolizines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1435573A (en) * | 1973-05-25 | 1976-05-12 | Wyeth John & Brother Ltd | Indoloquinolizines |
| GB2106909B (en) * | 1981-10-07 | 1984-09-19 | Wyeth John & Brother Ltd | Benzoquinolizines |
| IE57014B1 (en) * | 1983-03-25 | 1992-03-11 | Wyeth John & Brother Ltd | Benzoquinolizines |
| ES8609323A1 (es) * | 1984-02-02 | 1986-07-16 | Merck & Co Inc | Un procedimiento para la preparacion de hexahidro-arilquinolizinas sustituidas. |
| NZ216283A (en) * | 1985-06-03 | 1989-10-27 | Merck & Co Inc | Hexahydro arylquinolizine derivatives and pharmaceutical compositions |
-
1987
- 1987-08-18 NZ NZ221485A patent/NZ221485A/en unknown
- 1987-08-19 AU AU77205/87A patent/AU597412B2/en not_active Ceased
- 1987-08-19 IL IL83586A patent/IL83586A/xx not_active IP Right Cessation
- 1987-08-26 AT AT87307541T patent/ATE78482T1/de active
- 1987-08-26 EP EP87307541A patent/EP0259092B1/en not_active Expired - Lifetime
- 1987-08-26 PT PT85593A patent/PT85593B/pt not_active IP Right Cessation
- 1987-08-26 ES ES87307541T patent/ES2044944T3/es not_active Expired - Lifetime
- 1987-08-26 CA CA000545453A patent/CA1288435C/en not_active Expired - Lifetime
- 1987-08-26 DE DE8787307541T patent/DE3780542T2/de not_active Expired - Fee Related
- 1987-08-27 DK DK447387A patent/DK447387A/da not_active Application Discontinuation
- 1987-08-27 ZA ZA876400A patent/ZA876400B/xx unknown
- 1987-08-28 JP JP62214979A patent/JP2582799B2/ja not_active Expired - Lifetime
- 1987-08-28 KR KR870009444A patent/KR880002869A/ko not_active Withdrawn
-
1992
- 1992-08-27 GR GR920401865T patent/GR3005537T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR880002869A (ko) | 1988-05-12 |
| DE3780542D1 (en) | 1992-08-27 |
| PT85593B (pt) | 1990-05-31 |
| PT85593A (en) | 1987-09-01 |
| DE3780542T2 (de) | 1993-01-07 |
| ZA876400B (en) | 1988-02-25 |
| NZ221485A (en) | 1991-04-26 |
| IL83586A (en) | 1991-12-15 |
| JP2582799B2 (ja) | 1997-02-19 |
| AU597412B2 (en) | 1990-05-31 |
| AU7720587A (en) | 1988-03-03 |
| JPS63139183A (ja) | 1988-06-10 |
| ATE78482T1 (de) | 1992-08-15 |
| IL83586A0 (en) | 1988-01-31 |
| EP0259092A1 (en) | 1988-03-09 |
| CA1288435C (en) | 1991-09-03 |
| ES2044944T3 (es) | 1994-01-16 |
| GR3005537T3 (da) | 1993-06-07 |
| DK447387D0 (da) | 1987-08-27 |
| EP0259092B1 (en) | 1992-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU94027569A (ru) | Органические соли n,n'-диацетилцистина, способ получения, фармацевтическая композиция, способы лечения | |
| PT87542A (pt) | Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease | |
| NO162965C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydrotieno-(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater. | |
| DE3862928D1 (de) | Chinazolinon-derivate. | |
| FI885460L (fi) | Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi | |
| AU1578688A (en) | Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines | |
| NO880452D0 (no) | Fremgangsmaate for fremstilling av nye polyaminderivater. | |
| IE45989L (en) | Piperidine compounds. | |
| NO871295D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| IT8647625A0 (it) | Preparati farmaceutici con efficacia analgesica, nonche' loro produzione ed impiego | |
| NO870049L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| DK597687D0 (da) | Imidazolidinonforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat dermed | |
| DK447387D0 (da) | Hexahydroarylquinolizinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse | |
| NO863373L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater. | |
| NO167734C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater. | |
| NO874850D0 (no) | Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav. | |
| DK45385D0 (da) | Hexahydroarylquinolizin og farmaceutisk praeparat indeholdende en saadanforbindelse | |
| NO167456C (no) | Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse 7-(3-amino-1-pyrrolidinyl)-8-brom-1-syklopropyl-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre | |
| ES2005042A6 (es) | Procedimiento de preparar derivados de aminoacidos que tienen actividad sobre el sistema nervioso central. | |
| FI895937A7 (fi) | Uusia imidatsolidiinijohdannaisia, menetelmiä niiden valmistamiseksi, kuten myös näitä yhdisteitä sisältäviä lääkkeitä | |
| NO167801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater. | |
| DE3674323D1 (de) | 4-methoxyisophthalsaeurederivat mit pharmakologischer wirksamkeit gegen thromboembolische erkrankung und verfahren zu dessen herstellung. | |
| SE8305362D0 (sv) | Novel substituted phenylazacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds | |
| NO863005D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater. | |
| BG42833A3 (bg) | Метод за получаване на 1,3-бис/диметиламино/-2-пропил- 4-хлорфеноксиацетат |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |